...
首页> 外文期刊>Molecular medicine reports >shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway
【24h】

shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway

机译:shRNA介导的TARBP2沉默通过JNK / STAT3 / AKT途径抑制NCI-H1299非小细胞肺癌细胞的侵袭和迁移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Metastasis is a major cause of lung cancer-associated mortality. The current study aimed to investigate the effects and mechanisms of TAR (human immunodeficiency virus 1) RNA binding protein 2 (TARBP2) in the invasion and migration of non-small cell lung cancer in vitro. The highly metastatic cell clone H1299/M02 was obtained by TARBP2 overexpression. Expression of TARBP2 in H1299/M02 was also downregulated to different levels via small hairpin RNAs (shRNAs). Subsequent to TARBP2 silencing, the proliferation of H1299/M02 cells was predominantly unaffected, while invasion and migration were significantly inhibited. A positive correlation was observed between invasion and migration and the level of TARBP2 silencing in vitro. Western blotting and reverse transcription-quantitative polymerase chain reaction indicated that the protein expression levels of amyloid (A4) precursor protein (APP) and zinc finger protein 395 (ZNF395) were upregulated, while expression levels of pro-metastatic proteins including interleukin (IL)-1, IL-8, cyclooxygenase (COX)-2, matrix metalloproteinase 2 (MMP2) and MMP9 were downregulated. Phosphorylation of c-Jun N-terminal kinase (JNK), signal transducer and activator of transcription 3 (STAT3) and protein kinase B (AKT) were also inhibited. Overexpression of TARBP2 was suggested to be involved in the metastasis of H1299/M02 cells. Silencing of TARBP2 was able to upregulate levels of APP and ZNF395, in addition to inhibiting metastasis-promoting cytokines, the JNK/STAT3/AKT pathway and COX-2 to attenuate the invasion and migration of cancer cells.
机译:转移是与肺癌相关的死亡率的主要原因。目前的研究旨在调查TAR(人类免疫缺陷病毒1)RNA结合蛋白2(TARBP2)在非小细胞肺癌体外侵袭和迁移中的作用和机制。通过TARBP2过表达获得高度转移性细胞克隆H1299 / M02。通过小发夹RNA(shRNA),H1299 / M02中的TARBP2表达也被下调至不同水平。 TARBP2沉默后,H1299 / M02细胞的增殖主要不受影响,而侵袭和迁移受到明显抑制。体外侵袭和迁移与TARBP2沉默水平之间存在正相关。 Western印迹和逆转录定量聚合酶链反应表明淀粉样蛋白(A4)前体蛋白(APP)和锌指蛋白395(ZNF395)的蛋白表达水平上调,而包括白介素(IL)在内的前转移蛋白的表达水平。 -1,IL-8,环氧合酶(COX)-2,基质金属蛋白酶2(MMP2)和MMP9下调。 c-Jun N末端激酶(JNK),信号转导和转录激活因子3(STAT3)和蛋白激酶B(AKT)的磷酸化也受到抑制。 TARBP2的过表达被认为与H1299 / M02细胞的转移有关。沉默的TARBP2能够上调APP和ZNF395的水平,除了抑制促进转移的细胞因子,JNK / STAT3 / AKT途径和COX-2来减弱癌细胞的侵袭和迁移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号